These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 29795392

  • 1. Understanding the Connection between Nanoparticle Uptake and Cancer Treatment Efficacy using Mathematical Modeling.
    Brocato TA, Coker EN, Durfee PN, Lin YS, Townson J, Wyckoff EF, Cristini V, Brinker CJ, Wang Z.
    Sci Rep; 2018 May 24; 8(1):7538. PubMed ID: 29795392
    [Abstract] [Full Text] [Related]

  • 2. Enhanced chemotherapeutic efficacy of the low-dose doxorubicin in breast cancer via nanoparticle delivery system crosslinked hyaluronic acid.
    Wang Q, Zhong Y, Liu W, Wang Z, Gu L, Li X, Zheng J, Du H, Zhong Z, Xie F.
    Drug Deliv; 2019 Dec 24; 26(1):12-22. PubMed ID: 30691317
    [Abstract] [Full Text] [Related]

  • 3. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y, Zhang J, Cheng R, Deng C, Meng F, Xie F, Zhong Z.
    J Control Release; 2015 May 10; 205():144-54. PubMed ID: 25596560
    [Abstract] [Full Text] [Related]

  • 4. Enhanced anti-tumor efficacy and reduced cardiotoxicity of doxorubicin delivered in a novel plant virus nanoparticle.
    Alemzadeh E, Dehshahri A, Dehghanian AR, Afsharifar A, Behjatnia AA, Izadpanah K, Ahmadi F.
    Colloids Surf B Biointerfaces; 2019 Feb 01; 174():80-86. PubMed ID: 30445253
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin.
    Abumanhal-Masarweh H, Koren L, Zinger A, Yaari Z, Krinsky N, Kaneti G, Dahan N, Lupu-Haber Y, Suss-Toby E, Weiss-Messer E, Schlesinger-Laufer M, Shainsky-Roitman J, Schroeder A.
    J Control Release; 2019 Feb 28; 296():1-13. PubMed ID: 30615983
    [Abstract] [Full Text] [Related]

  • 8. Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer.
    Moura V, Lacerda M, Figueiredo P, Corvo ML, Cruz ME, Soares R, de Lima MC, Simões S, Moreira JN.
    Breast Cancer Res Treat; 2012 May 28; 133(1):61-73. PubMed ID: 21805188
    [Abstract] [Full Text] [Related]

  • 9. A polymeric nanoparticle consisting of mPEG-PLA-Toco and PLMA-COONa as a drug carrier: improvements in cellular uptake and biodistribution.
    Yi Y, Kim JH, Kang HW, Oh HS, Kim SW, Seo MH.
    Pharm Res; 2005 Feb 28; 22(2):200-8. PubMed ID: 15783067
    [Abstract] [Full Text] [Related]

  • 10. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
    Tao X, Gou J, Zhang Q, Tan X, Ren T, Yao Q, Tian B, Kou L, Zhang L, Tang X.
    Biomater Sci; 2018 Jun 25; 6(7):1869-1881. PubMed ID: 29808221
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
    Pan C, Liu Y, Zhou M, Wang W, Shi M, Xing M, Liao W.
    Int J Nanomedicine; 2018 Jun 25; 13():1119-1137. PubMed ID: 29520140
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
    Zhao Y, Houston ZH, Simpson JD, Chen L, Fletcher NL, Fuchs AV, Blakey I, Thurecht KJ.
    Mol Pharm; 2017 Oct 02; 14(10):3539-3549. PubMed ID: 28880092
    [Abstract] [Full Text] [Related]

  • 15. Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor models.
    Song G, Darr DB, Santos CM, Ross M, Valdivia A, Jordan JL, Midkiff BR, Cohen S, Nikolaishvili-Feinberg N, Miller CR, Tarrant TK, Rogers AB, Dudley AC, Perou CM, Zamboni WC.
    Clin Cancer Res; 2014 Dec 01; 20(23):6083-95. PubMed ID: 25231403
    [Abstract] [Full Text] [Related]

  • 16. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
    Qi WW, Yu HY, Guo H, Lou J, Wang ZM, Liu P, Sapin-Minet A, Maincent P, Hong XC, Hu XM, Xiao YL.
    Mol Pharm; 2015 Mar 02; 12(3):675-83. PubMed ID: 25584860
    [Abstract] [Full Text] [Related]

  • 17. Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models.
    Hadla M, Palazzolo S, Corona G, Caligiuri I, Canzonieri V, Toffoli G, Rizzolio F.
    Nanomedicine (Lond); 2016 Sep 02; 11(18):2431-41. PubMed ID: 27558906
    [Abstract] [Full Text] [Related]

  • 18. Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy.
    Zhang C, Pan D, Luo K, She W, Guo C, Yang Y, Gu Z.
    Adv Healthc Mater; 2014 Aug 02; 3(8):1299-308. PubMed ID: 24706635
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.